Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

INNT - Innovate Biopharmaceuticals Inc.

Previous close
0.56
0.560   100.000%

Share volume: 0
Last Updated: Fri 01 May 2020 10:00:01 PM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 20%
Dept financing 49%
Liquidity 5%
Performance 19%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.56
P/E Ratio 
N/A
DAY RANGE
$0.56 - $0.56
EPS 
-$0.78
52 WEEK RANGE
$0.37 - $1.67
52 WEEK CHANGE
-$63.40
MARKET CAP 
23.142 M
YIELD 
N/A
SHARES OUTSTANDING 
41.325 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$33,832,654
AVERAGE 10 VOLUME 
$577,270
AVERAGE 30 VOLUME 
$312,245
Company detail
CEO: Sandeep Laumas
Region: US
Website: http://www.innovatebiopharma.com
Employees: 8
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.

Recent news